Dynavax Technologies (DVAX) Stock: Headed Up On Clinical Data
Dynavax Technologies Corporation (NASDAQ: DVAX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced positive interim data from a clinical trial over the weekend. Of course, the news has excited investors who are sending the stock on a run for the top. Today, we’ll talk … Read more